GlobeStar Therapeutics Corp

GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is headquartered in Richland, Washington. The company went IPO on 2011-05-21. The firm is focused on introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The firm owns the global license from the inventors, who are based in Italy.

Peers: ACTAVIA LIFE SCIENCES, INC. Allena Pharmaceuticals, Inc. GridAI Technologies Corp International Stem Cell Corp Innoveren Scientific, Inc. NovAccess Global Inc. PREMIER BIOMEDICAL INC

Dive deeper

Financial snapshot data is not available right now.

Stock Price

Market Cap: $124.11 Thousand